Skip to content

Chromosomal Effect in vivo of Exposure to Lysergic Acid Diethylamide

Robert S. Sparkes, John Melnyk, Louis P. Bozzetti

Science June 21, 1968 DOI: 10.1126/science.160.3834.1343 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational study Peer reviewed
Population Persons exposed to lysergic acid diethylamide
Intervention lysergic acid diethylamide
Topics LSD
Keywords In vivo Pharmacology Toxicology Genetics Biochemistry Receptor
Citations 63
Key findings Exposure to lysergic acid diethylamide did not cause significant chromosomal damage.

Abstract

Chromosome studies of persons exposed to lysergic acid diethylamide, either self-administered or received during medical therapy, failed to demonstrate significant chromosomal damage.

Comparable studies

Other observational and cohort studies on LSD, most cited first.

Study Year Design Participants
Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution. Human participants 2016 Observational cohort
Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin Humans 2017 Observational study
Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. USA adult respondents from the National Survey on Drug Use and Health (2008-2012) 2015 Observational cohort n = 190,000
Psychedelics not linked to mental health problems or suicidal behavior: A population study Randomly selected United States adults 2015 Observational cohort n = 135,095
Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD. Healthy human participants 2018 Observational study with computational modeling

Citations in the library

Explore topics